NINEJP in BioJapan 2026

October 7(Wed)-9(Fri),2026

BioJapan at PACIFICO Yokohama

Experience a special event by NINEJP,
Japan’s largest platform for university-launched,
R&D-focused startups.

October 8 (Thu) 13:00-18:30

Global Pitch
Conference

Pitches by researchers and university-based startups recommended by nine platforms across Japan, followed by a Networking session where participants can connect directly with the presenters.
Learn more about Global Pitch Conference
October 9 (Fri) 14:30-16:30

Special Panel
& Pitch Session

(Photo courtesy of Imperial Enterprise Lab / WE Innovate)
A session exploring creative challenges and global opportunities through a panel discussion and a pitch competition featuring women entrepreneurs.
Learn more about Special Panel & Pitch Session
October 7 (Wed) – 9 (Fri)

Booth Exhibition

Cutting-edge research seeds and university-based startups from across Japan, with direct outreach and business meetings available through BioJapan's paid partnering system.
Learn more about Booth Exhibition

What is BioJapan 2026?

First held in 1986, BioJapan is the world's longest-running international biotechnology exhibition.
In 2025, it welcomed 22,167 visitors and 1,134 exhibiting companies and organizations. Through exhibitions, seminars, and its paid partnering system, BioJapan provides a business-matching platform that promotes industry–academia–government collaboration and open innovation in Japan and abroad. Free visitor registration for BioJapan provides access to NINEJP sessions and booth exhibits.

Global Pitch
Conference NINEJP Innovation Award in BioJapan2026

Research Seeds Session

Academia Research Seeds Session

Presentation pitches by researchers from nine platforms across Japan.
(Presentations in English / Simultaneous Interpretation Available)

Date & Time /: October 8 (Thu), 2026, 13:00–14:40
Venue /: G301, 3F, North, PACIFICO Yokohama

The following pages, which provide an overview of each researcher's or team's research, will also be published on a rolling basis:
・researchmap
・Made in Campus
Partnering account holders may also contact the researchers or teams in advance. The partnering service is a paid BioJapan service.

Made in Campus (Separate Registration Required)

13:00-
13:05

Opening
13:05-
13:15

Reimagining NTM Treatment ~Antimicrobial-Independent Therapeutics for Nontuberculous Mycobacterial Disease~

Nagasaki University　Asst. Prof. Satoshi Mizuta
- View on researchmap
13:15-
13:25

Development of the World's First ATP6AP2-Targeted Wnt Inhibitor

Department of Pharmacology, Faculty of Medicine, Kagawa University　Prof. Akira Nishiyama
- View on researchmap
13:25-
13:35

Sales launch of neural activity monitoring system using ultra-small implantable brain sensors

Nara Institute of Science and Technology　Prof. Motoshi Sobue

※Research Professor Jun Ohta
- View on researchmap
13:35-
13:45

Establishment of large-scale production and quality control technologies for high-quality exosome formulations

Kanazawa University　Prof. Rikinari Hanayama
13:45-
13:55

Cancer Gene Testing and Drug Discovery Using Patented Cultivation Technology for Human Cancer Cells.

Fujita Health University, Research Promotion Headquarters, University Startup Promotion Center　Director, MBA　Sho Kawabe

※Prof. Naoki Yamamoto
- View on researchmap
13:55-
14:05

Revolutionizing Preeclampsia Treatment via Removal and Detection of Pathogenic Exosomes

Hoshino Laboratory, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo　EIR　Hiroshi Momose

※Prof. Ayuko Hoshino
14:05-
14:15

Development of anti-cancer drugs using immune-modulating factors

Gunma University　Prof. Keisuke Nimura
- View on researchmap
14:15-
14:25

Development of novel megalin antagonists against acute kidney injury

Niigata University　Specially Appointed Professor　Akihiko Saito
- View on researchmap
14:25-
14:35

Development culture media and process using AI and analytical technologies.

Kitami Institute of Technology　Prof. Masaaki Konishi
- View on researchmap

Startup Session

Presentation pitches by startups from nine platforms across Japan.
(Presentations in English / Simultaneous Interpretation Available)

Date & Time /: October 8 (Thu), 2026, 15:00–16:40
Venue /: G301, 3F, North, PACIFICO Yokohama

The following pages, which provide an overview of each company's research, will also be published on a rolling basis:
・researchmap
・Made in Campus
Partnering account holders may also contact the companies in advance. The partnering service is a paid BioJapan service.

Made in Campus (Separate Registration Required)

15:00-
15:05

Opening
15:05-
15:15

Development of a Robotic System to Assist Precise Microsurgical Procedures

F.MED Co., Ltd.　Co-Founder, CEO　Keita Shimomura

Kyushu University Spin-off Startup
15:15-
15:25

Accelerating Precision Breeding Across Species with Proprietary Genome-Editing Technology

Setsuro Tech Inc.　Account Sales　Shuya Nitta

Tokushima University Spin-off Startup
15:25-
15:35

Changing Patients' Lives with True Vascular Cell Therapy Using a Novel Stem Cell Technology

Revascular Bio Co., Ltd.　President & CEO　Kazuo Omori

Osaka University Spin-off Startup
15:35-
15:45

"From Lab to Kiosk": Scalable Robotic Platform for Decentralized Molecular Diagnostics

BioSeeds Co., Ltd.　President & Representative Director　Manish Biyani

Japan Advanced Institute of Science and Technology
15:45-
15:55

Expanding the uses of photoimmunotherapy with new light-irradiation technology

Illumi Medical Inc.　Akira Ito

Nagoya University Spin-off Startup
15:55-
16:05

Excipient that opens transdermal delivery options
for mid- and large-molecule drugs

Keihika Inc.　CEO　Kentaro Honda

University of Tsukuba Spin-off Startup
- View on researchmap
16:05-
16:15

The World's First Th7R Cell Therapy: A New Hope for Patients with Solid Tumors

ImmuniT Research Inc.　CEO　Masafumi Yasukochi

Saitama Medical University Spin-off Startup
16:15-
16:25

Xerostomia Therapy Designed to Balance Efficacy and Tolerability by Enhancing Physiological Salivary Secretion

SiccaNova Therapeutics Co., Ltd.　President & CEO　Keni Nii
16:25-
16:35

A Hokkaido University technology cutting microbial testing from 48 hours to half a day

LMusubi Co., Ltd　Founder & CEO　Yuri Habuto

Hokkaido University Spin-off Startup

Pitch Judge

Information on the Pitch Judges

Judged by accelerators and venture capitalists
with expertise in life sciences and biotechnology

Title

Name
Title

Name
Title

Name
Title

Name
Title

Name
Title

Name
Title

Name
Title

Name
Title

Name
Title

Name

FoundersNation, Co. Ltd CEO

Masaru Nagura

NetWorking

Networking Sponsored by LINK-J

Date & Time /: October 8 (Thu), 2026, 17:00-18:30 (Doors Open at 16:30)
Venue /: G404, 4F, North, PACIFICO Yokohama

16:30

Registration Opens
17:00

Global Pitch Conference Awards Ceremony & Networking
18:00

Closing Remarks (Venue Closes at 18:30)

Special Panel & Pitch Session

Courage to Create:
Inspiring Journeys
of Women
Entrepreneurs

This session combines a panel discussion and pitch session to highlight the innovation and global potential of women entrepreneurs. The first half of the session features a panel discussion exploring key challenges and strategies for supporting women entrepreneurs in expanding globally. The session will then shift to a pitch showcase featuring teams from Imperial College London's WE Innovate program, alongside women entrepreneurs and researchers from Japan's NINEJP platforms. Featuring experts and entrepreneurs from the United Kingdom and Japan, the session offers valuable insights and networking opportunities for aspiring innovators and ecosystem stakeholders alike.

Date & Time /: October 9 (Fri), 2026, 14:30–16:30
Venue /: F205, 2F, Annex Hall, PACIFICO Yokohama

14:30-15:30 Special Panel

on the Japan–UK women's entrepreneurship ecosystem

Panelist

Imperial College
London

Chantelle Young
Imperial College
London

Nadia Ahrazem
Red Capital, Co., Ltd.

Tomoko Inoue
Institute of Science
Tokyo

Kaori Iida

Moderator

FoundersNation, Co. Ltd CEO

Masaru Nagura

15:30-16:30 Special PitchComing Soon...

Booth Exhibition Next Bio-Innovation for the Future: From Lab to Global Markets

Date & Time /: October 7 (Wed) – 9 (Fri), 2026
Venue /: Exhibition Hall, Booth B-04, PACIFICO Yokohama

Booth List

HSFC
Kitami Institute of Technology

Development culture media and process using AI and analytical technologies.

Category

AI Applications, Biomanufacturing
MASP
SiccaNova Therapeutics Co., Ltd.

Xerostomia Therapy Designed to Balance Efficacy and Tolerability by Enhancing Physiological Salivary Secretion

Category

Pharma / Biotech
MASP
Blue Practice Co.,Ltd.

Visualizing treatment expertise with biomimetic models to accelerate personalized medicine

Category

Healthcare Digital Transformation, Development of Devices to Advance Cutting-Edge Medical Treatments
GTIE
Yokohama City University, Department of Urology

AI Molecular Diagnostic Platform for Kidney Cancer

Category

Drug Discovery Support Technologies, Diagnostic and Therapeutic Devices, AI Applications, and Healthcare Digital Transformation

View on researchmap
GTIE
Keihika Inc.

Excipient that opens transdermal delivery options for mid- and large-molecule drugs

Category

Pharma / Biotech, Drug Discovery Support Technologies

View on researchmap
Tongali
Fujita Health University, Research Promotion Headquarters

Next-Generation Cancer Genetic Testing Methods and Drug Discovery Using High-Efficiency Human Cancer Cell Isolation and Culture Technologies.

Category

Pharma / Biotech , Drug Discovery Support Technologies , Diagnostic and Therapeutic Devices

View on researchmap
TeSH
JAIST

a Nano-DDS Platform for Non-invasive Treatment and Enhanced Therapeutic Efficacy of Posterior Eye Diseases

Category

Pharma / Biotech
KSAC
Nara Institute of Science and Technology

Commercialization of Brain Activity Monitoring Systems Using Ultra-Miniaturized Implantable Brain Sensors and Brain Activity Measurement Support Services

Category

Diagnostic and Therapeutic Devices, Healthcare
KSAC
HOIST Corp.

NMIBC: tumor-selective, well-tolerated therapy. Pancreatic cancer: first-in-class ALKBH3 inhibitor.

Category

Pharma / Biotech

View on researchmap
PSI
Kagawa University, Faculty of Medicine, Department of Pharmacology

Development of the World's First ATP6AP2-Targeted Wnt Inhibitor

Category

Diagnostic and Therapeutic Devices, Healthcare

View on researchmap
PARKS
Nagasaki University,
Graduate School of Biomedical Sciences

Development of antimicrobial-independent therapeutics for refractory mycobacterial infections, including pulmonary non-tuberculous mycobacteria Disease

Category

Pharma / Biotech

View on researchmap
Coming Soon...

----

Category

----

View on researchmap View Partnering
Account